2026 Annual Meeting Program 

The 2026 ACCP Annual Meeting Program Committee, led by Drs. Neeraj Gupta and Cody Peer, invites you to Save the Date for the 2026 ACCP Annual Meeting, Sept 27 – 29, 2026, at the Bethesda N Marriott Hotel & Conf Ctr, N Bethesda, MD. Known for its welcoming and collegial environment, the 2026 ACCP Annual Meeting promises to be yet another excellent educational event designed to break down barriers and provide innovative education for a global audience of clinical pharmacology-focused professionals to learn, connect and contribute. Select between a variety of sessions in short or long format to meet your unique needs. Enjoy evening Poster Sessions & Receptions that provide a relaxing atmosphere to explore scientific Posters and network with colleagues, new and old.   

CME & CPE credits will be available to all attendees. A series of Student, Trainee & Early-stage Professional-focused events provide structured opportunities for young colleagues to become part of the greater clinical pharmacology community by engaging with career professionals who are eager to share their experiences and answer questions. Consistent with ACCP’s welcoming philosophy, reduced registration fees and travel grants (awarded by application process) will be available to colleagues from developing countries wishing to attend this exciting event.

Whether you are new to ACCP or a long-time member, we invite you to stay at the forefront of clinical pharmacology by joining us to learn, network and advance your practice. Put the 2026 ACCP Annual Meeting on your calendar as THE meeting to attend in 2026!

 

 Educational Sessions   

Saturday, September 26th

Pre-meeting Workshop (full day): Cardiac Safety in Drug Development: Navigating Risk from Preclinical to Labeling

Review Course (full day): Clinical Pharmacology Curriculum Review Course (American Board Clinical Pharmacology)

Sunday, September 27th

Plenary Session: Lisa von Moltke: Bridging Discovery & Impact: Clinical Pharmacology & Translational Science in the Era of Novel Therapeutic Modalities

Symposium 1: Where are we now in pediatric cancer drug development: 5 years of the RACE for Children Act

Symposium 2: Hot Topic: Current & Next Generation of GLP-1 Receptor Agonists and Obesity Drugs: Overcoming Clinical Pharmacology Challenges

Symposium 3: Sustainability in the Research and Development of Medicines: An Opportunity for Clinical Pharmacology

Monday, September 28th

Symposium 4: Leveraging Innovative Quantitative System Pharmacology, Artificial Intelligence & Machine Learning Approaches for Cytokine Release Syndrome Risk Management in T-Cell Redirecting Therapies

Symposium 5: Toward Global Harmonization of Mechanistic Modeling Assessment: Perspectives from EMA and FDA

Symposium 6: Pharmacogenetics in Specific Populations: Using Novel Experimental Approaches and Modeling & Simulation to “Solve” Complex Cases

Invited Keynote: Dr. Eileen Habelow: Harnessing Leadership and Collaboration to Drive Change

Symposium 7: Hot Topic: Integrating Agentic Artificial Intelligence into Quantitative Clinical Pharmacology: Promise, Practice, and Pitfalls

Symposium 8: When Rare Meets Young: Harnessing Clinical Pharmacology to Facilitate Dose Selection and Approval for Pediatric Rare Diseases

Tuesday, September 29th

Symposium 9: Maximizing Patient Outcomes: Immunogenicity Insights for Drug Development & Therapeutic Care

Symposium 10: Hot Topic: Enabling Safe and Informed Therapeutics in Lactation: Role of the Clinical Pharmacologist

Symposium 11: Transforming Clinical Pharmacology and Drug Safety: Enhancing Patient Safety Through Advanced Technology, Integrated Surveillance, Postmarket Strategies and Life Cycle Management

Symposium 12: The Need and Approaches for Ensuring Initial FDA Approved Dosing Applies to Real World Patients

Symposium 13: Molecules, Models, and Modalities from CAR-Ts to siRNAs: Clinical Pharmacology on the Frontier

Symposium 14: Rethinking Bridging: Understanding the Role of M&S and Strategic Approaches for Bridging Drug-Device Combinations

 

  

Early Bird Pricing*

For ease of planning, we have published Early Bird registration rates for the 2026 ACCP Annual Meeting, but please note that registration does not open until spring. These rates are subject to change, so be sure to save the date and stay tuned for when registration officially opens to secure the best rates!

2026 ACCP Annual Meeting Registration Rates

*Rates are subject to change.

Registration Categories

Early Bird Rates

Member – 3 Day

$1,215

Member – 1 Day

$640

 

 

Non-Member – 3 Day

$2,015

Non-Member – 1 Day

$810

 

 

US Government Colleague – 3 Day

$1,460

US Government Colleague – 1 Day

$695

 

 

Developing Country Member – 3 Day

$465

Developing Country Non-Member – 3 Day

$760

 

 

Student Member – 3 Day

$475

Student Member – 1 Day

$270

 

 

Student Non-Member – 3 Day

$660

Student Non-Member – 1 Day

$285

 

 

Student Member Developing Country – 3 Day

$330

Student Non-Member Developing Country – 3 Day

$460

Pre-Meeting Workshop (Full Day)

 

Member

$625

Non-Member

$805

US Government Colleague

$705

Developing Country Member

$260

Developing Country Non-Member

$305

Student (Member or Non-Member)

$280

Developing Country Student (Member or Non-Member)

$235

ABCP Review Course (Full Day)

 

Member

$595

Non-Member

$815

US Government Colleague

$675

Developing Country Member

$410

Developing Country Non-Member

$445

Student (Member or Non-Member)

$315

Developing Country Student (Member or Non-Member)

$295